Press Release | Mon Oct 22, 2012 9:00am EDT

PHASE IIa LAQUINIMOD TRIAL RESULTS SHOW POSITIVE DATA FOR POTENTIAL USE IN ACTIVE CROHN'S DISEASE

* Reuters is not responsible for the content in this press release.